FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2088403913> ?p ?o ?g. }

• W2088403913 endingPage "4482" @default.
• W2088403913 startingPage "4478" @default.
• W2088403913 abstract "Chimpanzees are susceptible to infection by divergent strains of human immunodeficiency virus type 1 (HIV-1), none of which cause clinical or immunological abnormalities. Chimpanzees were inoculated with one of four strains of HIV-1: human T-lymphotropic virus (HTLV) type IIIB, lymphadenopathy virus (LAV) type 1, HTLV type IIIRF, or an isolate from the brain of a patient with acquired immunodeficiency syndrome. Within 6 months after inoculation with the closely related strains HTLV-IIIB or LAV-1, six chimpanzees developed serum antibodies to the C-terminal half (amino acids 288-467) of the HTLV-IIIB external envelope glycoprotein gp120. Sera from five of those chimpanzees had HTLV-IIIB cell-fusion-inhibiting antibody titers greater than or equal to 20 at that time, indicating that they neutralized the infecting strain of HIV-1 in vitro. No antibodies to the carboxyl terminus of HTLV-IIIB gp120 were observed in sera of chimpanzees inoculated with HTLV-IIIRF or with the brain-tissue strain, and those sera did not neutralize HTLV-IIIB. A rabbit immunized with the C-terminal portion of gp120 acquired neutralizing antibodies that bound to four domains of the HTLV-IIIB external envelope as analyzed by reactivity to 536 overlapping nonapeptides of gp120. One of these domains in the variable region V3, with the amino acid sequence IRIQRGPGRAFVTIG (amino acids 307-321), bound to all chimpanzee sera that neutralized HTLV-IIIB but not to the serum of the HTLV-IIIRF-inoculated chimpanzee that did not neutralize HTLV-IIIB. The HTLV-IIIRF sequence at the same location, ITKGPGRVIYA, was recognized by the serum of the HTLV-IIIRF-inoculated chimpanzee but not by any sera of the HTLV-IIIB-inoculated or LAV-1-inoculated chimpanzees. The HTLV-IIIB residues RIQR and AFV and the HTLV-IIIRF residues lysine and VIYA, flanking a highly conserved beta-turn (GPGR), appear to be critical for antibody binding and subsequent type-specific virus neutralization. This neutralization epitope, putatively consisting of a loop between two cysteine residues (amino acids 296 and 331) connected by a disulfide bond, is immunodominant in HIV-1-infected chimpanzees and induces antibodies restricted to the homologous viral strain." @default.
• W2088403913 created "2016-06-24" @default.
• W2088403913 creator A5027502794 @default.
• W2088403913 creator A5035060802 @default.
• W2088403913 creator A5040038561 @default.
• W2088403913 creator A5049868099 @default.
• W2088403913 creator A5061380586 @default.
• W2088403913 creator A5066575559 @default.
• W2088403913 creator A5069131718 @default.
• W2088403913 creator A5076855289 @default.
• W2088403913 creator A5081477789 @default.
• W2088403913 date "1988-06-01" @default.
• W2088403913 modified "2023-10-04" @default.
• W2088403913 title "Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees." @default.
• W2088403913 cites W1578509365 @default.
• W2088403913 cites W1710012409 @default.
• W2088403913 cites W1768734130 @default.
• W2088403913 cites W1899501273 @default.
• W2088403913 cites W1970405931 @default.
• W2088403913 cites W1973145069 @default.
• W2088403913 cites W1975403569 @default.
• W2088403913 cites W1991661151 @default.
• W2088403913 cites W2024353184 @default.
• W2088403913 cites W2027559384 @default.
• W2088403913 cites W2029883296 @default.
• W2088403913 cites W2032790020 @default.
• W2088403913 cites W2048691284 @default.
• W2088403913 cites W2054724326 @default.
• W2088403913 cites W2059770652 @default.
• W2088403913 cites W2104470055 @default.
• W2088403913 cites W2120155625 @default.
• W2088403913 cites W2140008350 @default.
• W2088403913 cites W2149038808 @default.
• W2088403913 cites W2149464124 @default.
• W2088403913 cites W2219884190 @default.
• W2088403913 cites W2314456879 @default.
• W2088403913 cites W2325580204 @default.
• W2088403913 cites W2395241119 @default.
• W2088403913 cites W2418848006 @default.
• W2088403913 doi "https://doi.org/10.1073/pnas.85.12.4478" @default.
• W2088403913 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/280453" @default.
• W2088403913 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2454471" @default.
• W2088403913 hasPublicationYear "1988" @default.
• W2088403913 type Work @default.
• W2088403913 sameAs 2088403913 @default.
• W2088403913 citedByCount "476" @default.
• W2088403913 countsByYear W20884039132012 @default.
• W2088403913 countsByYear W20884039132013 @default.
• W2088403913 countsByYear W20884039132014 @default.
• W2088403913 countsByYear W20884039132015 @default.
• W2088403913 countsByYear W20884039132016 @default.
• W2088403913 countsByYear W20884039132017 @default.
• W2088403913 countsByYear W20884039132019 @default.
• W2088403913 countsByYear W20884039132022 @default.
• W2088403913 crossrefType "journal-article" @default.
• W2088403913 hasAuthorship W2088403913A5027502794 @default.
• W2088403913 hasAuthorship W2088403913A5035060802 @default.
• W2088403913 hasAuthorship W2088403913A5040038561 @default.
• W2088403913 hasAuthorship W2088403913A5049868099 @default.
• W2088403913 hasAuthorship W2088403913A5061380586 @default.
• W2088403913 hasAuthorship W2088403913A5066575559 @default.
• W2088403913 hasAuthorship W2088403913A5069131718 @default.
• W2088403913 hasAuthorship W2088403913A5076855289 @default.
• W2088403913 hasAuthorship W2088403913A5081477789 @default.
• W2088403913 hasBestOaLocation W20884039132 @default.
• W2088403913 hasConcept C108625454 @default.
• W2088403913 hasConcept C14086860 @default.
• W2088403913 hasConcept C153911025 @default.
• W2088403913 hasConcept C159047783 @default.
• W2088403913 hasConcept C159654299 @default.
• W2088403913 hasConcept C195616568 @default.
• W2088403913 hasConcept C203014093 @default.
• W2088403913 hasConcept C2522874641 @default.
• W2088403913 hasConcept C86803240 @default.
• W2088403913 hasConceptScore W2088403913C108625454 @default.
• W2088403913 hasConceptScore W2088403913C14086860 @default.
• W2088403913 hasConceptScore W2088403913C153911025 @default.
• W2088403913 hasConceptScore W2088403913C159047783 @default.
• W2088403913 hasConceptScore W2088403913C159654299 @default.
• W2088403913 hasConceptScore W2088403913C195616568 @default.
• W2088403913 hasConceptScore W2088403913C203014093 @default.
• W2088403913 hasConceptScore W2088403913C2522874641 @default.
• W2088403913 hasConceptScore W2088403913C86803240 @default.
• W2088403913 hasIssue "12" @default.
• W2088403913 hasLocation W20884039131 @default.
• W2088403913 hasLocation W20884039132 @default.
• W2088403913 hasLocation W20884039133 @default.
• W2088403913 hasLocation W20884039134 @default.
• W2088403913 hasOpenAccess W2088403913 @default.
• W2088403913 hasPrimaryLocation W20884039131 @default.
• W2088403913 hasRelatedWork W1516164909 @default.
• W2088403913 hasRelatedWork W1567514421 @default.
• W2088403913 hasRelatedWork W1893449782 @default.
• W2088403913 hasRelatedWork W1998034482 @default.
• W2088403913 hasRelatedWork W2044405416 @default.
• W2088403913 hasRelatedWork W2060284918 @default.
• W2088403913 hasRelatedWork W2107850987 @default.
• W2088403913 hasRelatedWork W2113609740 @default.

• next